Here’s why we believe GoodRx (GDRX) stock is worth considering: It is expanding, generating cash, and is available at a notable valuation discount. Let’s examine the figures.Cash Yield: GoodRx presents an impressive cash flow yield of 10.0%.Growing: The revenue growth over the last 12 months stands at 3.2%, which isn't remarkable, but your cash reserves are likely to increase.Valuation Discount: GDRX stock is currently priced at 35% below its 3-month high, 46% under its 1-year high, and 63% lower than its 2 ...